Substantial Shareholding

30 Jul 2008 15:25



30 July 2008

REGEN THERAPEUTICS PLC 

("ReGen" or the "Company"; Ticker: (RGT))

TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

ReGen Therapeutics Plc

2. Reason for the notification:

An acquisition or disposal of voting rights

3. Full name of person(s) subject to the notification obligation (iii):

Andrew Clement Wilson

4. Full name of shareholder(s) (if difference from 3):

As above

5. Date of the transaction and date on which the threshold is crossed or reached (v):

29 July 2008

6. Date on which issued notified:

30 July 2008

7. Threshold(s) that is/are crossed or reached:

15% 

8. Notified details 

A: Voting rights attached to shares

Class/type of share if possible using the ISIN Code GB00B28XMY25

Situation Previous to the triggering transaction (vi) -

Number of Shares 1,700,000

Number of Voting Rights (viii) 1,700,000

Resulting situation after the triggering transaction (viii) -

Number of Shares 1,724,000

Number of Voting Rights - Direct (x) 1,724,000

Number of Voting Rights - Indirect (xi) N/A

% of voting rights - Direct 15.01%

% of voting rights - Indirect N/A

B: Financial Instruments

Resulting situation after the triggering transaction (xii)

Type of financial instrument N/A

Expiration date (xiii) N/A

Exercise/Conversion Period/Date (xiv) N/A

Number of voting rights that may be acquired if the 

instrument is exercised/converted N/A

% of voting rights N/A

Total (A+B)

Number of voting rights 1,724,000

% of voting rights 15.01

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):

Shares are held in own name

Proxy Voting:

10. Name of the proxy holder: N/A

11. Number of voting rights proxy holder will cease to hold: N/A

12.Date on which proxy holder will cease to hold voting rights: N/A

13. Additional information: N/A

14. Contact name: N/A

15. Contact telephone number: N/A

For further information:

Percy Lomax

ReGen Therapeutics Plc

Tel: +44 (0) 207 153 4920

Roland Cornish / Felicity Geidt

Beaumont Cornish Limited

Tel: +44(0) 207 628 3396